Sugano N - Search Results

1

Kidoguchi S, Sugano N, Yokoo T, Kaneko H, Akazawa H, Mukai M, Node K, Yano Y, Nishiyama A. Kidoguchi S, et al. Among authors: sugano n. Am J Hypertens. 2022 Sep 1;35(9):767-783. doi: 10.1093/ajh/hpac066. Am J Hypertens. 2022. PMID: 35595533 Review.

2

Effect of aliskiren in chronic kidney disease patients with refractory hypertension undergoing hemodialysis: a randomized controlled multicenter study.

Kuriyama S, Yokoyama K, Hara Y, Sugano N, Yokoo T, Hosoya T. Kuriyama S, et al. Among authors: sugano n. Clin Exp Nephrol. 2014 Oct;18(5):821-30. doi: 10.1007/s10157-013-0914-5. Epub 2013 Nov 20. Clin Exp Nephrol. 2014. PMID: 24253615 Clinical Trial.

3

Monitoring of body water composition by the simultaneous use of bioelectrical impedance analysis and Crit-Line(®) during hemodialysis.

Sugano N, Yokoyama K, Kato N, Hara Y, Endo S, Mitome J, Kin T, Tokudome G, Kuriyama S, Hosoya T, Yokoo T. Sugano N, et al. Clin Exp Nephrol. 2014 Dec;18(6):944-51. doi: 10.1007/s10157-014-0944-7. Epub 2014 Feb 12. Clin Exp Nephrol. 2014. PMID: 24519373

4

Mechanistic view of renal protective action of calcium channel blockade.

Sugano N, Hayashi K, Hosoya T, Yokoo T. Sugano N, et al. Curr Hypertens Rev. 2013 Aug;9(3):187-92. doi: 10.2174/157340210903140415124048. Curr Hypertens Rev. 2013. PMID: 24749517 Review.

5

Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation.

Furuya M, Yamamoto I, Kobayashi A, Nakada Y, Sugano N, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Yokoyama K, Yokoo T. Furuya M, et al. Among authors: sugano n. Nephrology (Carlton). 2014 Jun;19 Suppl 3:31-4. doi: 10.1111/nep.12245. Nephrology (Carlton). 2014. PMID: 24842819

6

Serum uric acid and the incidence of CKD and hypertension.

Kuriyama S, Maruyama Y, Nishio S, Takahashi Y, Kidoguchi S, Kobayashi C, Takahashi D, Sugano N, Hosoya T, Yokoo T. Kuriyama S, et al. Among authors: sugano n. Clin Exp Nephrol. 2015 Dec;19(6):1127-34. doi: 10.1007/s10157-015-1120-4. Epub 2015 May 13. Clin Exp Nephrol. 2015. PMID: 25967597 Free PMC article.

7

Successful long-term effects of direct renin inhibitor aliskiren in a patient with atherosclerotic renovascular hypertension.

Morisawa N, Sugano N, Yamakawa T, Kuriyama S, Yokoo T. Morisawa N, et al. Among authors: sugano n. CEN Case Rep. 2017 May;6(1):66-73. doi: 10.1007/s13730-016-0246-x. Epub 2017 Jan 16. CEN Case Rep. 2017. PMID: 28509129 Free PMC article.

8

Forced expression of vascular endothelial growth factor-A in podocytes decreases mesangial cell numbers and attenuates endothelial cell differentiation in the mouse glomerulus.

Suyama M, Miyazaki Y, Matsusaka T, Sugano N, Ueda H, Kawamura T, Ogura M, Yokoo T. Suyama M, et al. Among authors: sugano n. Clin Exp Nephrol. 2018 Apr;22(2):266-274. doi: 10.1007/s10157-017-1450-5. Epub 2017 Aug 3. Clin Exp Nephrol. 2018. PMID: 28776225

9

Gender interaction of uric acid in the development of hypertension.

Nishio S, Maruyama Y, Sugano N, Hosoya T, Yokoo T, Kuriyama S. Nishio S, et al. Among authors: sugano n. Clin Exp Hypertens. 2018;40(5):446-451. doi: 10.1080/10641963.2017.1392556. Epub 2017 Nov 28. Clin Exp Hypertens. 2018. PMID: 29182449

10

Azilsartan causes natriuresis due to its sympatholytic action in kidney disease.

Kidoguchi S, Sugano N, Takane K, Takahashi Y, Morisawa N, Yarita M, Hayashi-Ishikawa N, Tokudome G, Yokoo T. Kidoguchi S, et al. Among authors: sugano n. Hypertens Res. 2019 Oct;42(10):1507-1517. doi: 10.1038/s41440-019-0271-1. Epub 2019 May 28. Hypertens Res. 2019. PMID: 31138899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

631 results

Search Page